Home › Compare › HMTLY vs ABBV
HMTLY yields 0.75% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, HMTLY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMTLY + ABBV for your $10,000?
Hitachi Metals, Ltd. manufacture and sell specialty steel products, functional components and equipment, magnetic materials and applications/power electronics materials, wires and cables, and related products in Japan, North America, Asia, Europe, and internationally. The company's Specialty Steel Products segment offers molds and tool steels, rolls for steel mills, injection molding machine parts, structural ceramic products, and steel-frame joints for construction; automobile-related materials, razor and blade materials, precision cast components, and aircraft- and energy-related materials; and display-related materials, semiconductor and other package materials, and battery-related materials. Its Functional Components and Equipment segment provides HNM ductile cast iron products, cast iron products for transportation equipment, heat-resistant exhaust casting components, and Aluminum components; and piping and infrastructure components. The company's Magnetic Materials and Applications/Power Electronics Materials segment offers rare-earth magnets, ferrite magnets, and other magnets and applied products; and amorphous metals, nanocrystalline magnetic materials, soft ferrite, and applied products, as well as ceramic components. Its Wires, Cables, and Related Products segment provides industrial cables, electronic wires, electric equipment materials, cable assemblies, and industrial rubber products; and automotive electronic components and brake hoses. The company was founded in 1910 and is headquartered in Tokyo, Japan. Hitachi Metals, Ltd. is a subsidiary of Hitachi, Ltd.
Full HMTLY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.